Short- and long-term outcomes after laparoscopic and open hepatic resection: systematic review and meta-analysis  by Mirnezami, Reza et al.
REVIEW ARTICLE
Short- and long-term outcomes after laparoscopic and open hepatic
resection: systematic review and meta-analysis
Reza Mirnezami1, Alexander H. Mirnezami2, Kandiah Chandrakumaran3, Mohammad Abu Hilal4, Neil W. Pearce4,
John N. Primrose4 & Robert P. Sutcliffe5
1Department of Surgery, Imperial Healthcare NHS Trust, London 2Somers Cancer Research Building, University of Southampton Cancer Sciences Division,
Southampton University Hospital NHS Trust, Southampton, 3Department of Surgery, Basingstoke and North Hampshire Hospital NHS Trust, Basingstoke,
4Department of Hepatobiliary Surgery, Southampton University Hospital NHS Trust, Southampton and 5Hepatobiliary Unit, Queen Elizabeth Hospital,
Birmingham, UK
Abstracthpb_295 295..308
Background: Laparoscopic liver resection (LLR) is now considered a feasible alternative to open liver
resection (OLR) in selected patients. Nevertheless studies comparing LLR and OLR are few and concerns
remain about long-term oncological equivalence. The present study compares outcomes with LLR vs.
OLR using meta-analytical methods.
Methods: Electronic literature searches were conducted to identify studies comparing LLR and OLR.
Short-term outcomes evaluated included operating time, blood loss, length of hospital stay, peri-
operative morbidity and resection margin status. Longer-term outcomes included local and distant
recurrence, and overall (OS) and disease-free survival (DFS). Meta-analyses were performed using the
Mantel–Haenszel method and Cohen's d method, with results expressed as odds ratio (OR) or standard-
ized mean difference (SMD), respectively, with 95% confidence intervals (CI).
Results: Twenty-six studies met the inclusion criteria with a population of 1678 patients. LLR resulted in
longer operating time, but reduced blood loss, portal clamp time, overall and liver-specific complications,
ileus and length of stay. No difference was found between LLR and OLR for oncological outcomes.
Discussion: LLR has short-term advantages and seemingly equivalent long-term outcomes and can be
considered a feasible alternative to open surgery in experienced hands.
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Introduction
Over the past 30 years surgery of the gastro-intestinal (GI) tract has
been revolutionized by minimally invasive techniques. Laparo-
scopic surgery is now considered the approach of choice for a
variety of procedures, including cholecystectomy,1 appendicec-
tomy,2 splenectomy,3 anti-reflux surgery4 and more recently col-
orectal resection.5 Proven benefits of laparoscopic surgery include
reducedpost-operative pain, shorteneddurationof hospitalization
and improved cosmetic outcome,andhave been reported in almost
all surgical sub-specialties. The successful application of laparos-
copy to solid-organ surgery, such as hepatic resection, represents a
potential hurdle and liver surgeons have, until relatively recently,
been wary of embracing the laparoscopic movement. The first
laparoscopic liver resection (LLR) for benign disease was reported
in 1992 by Gagner,6 and the first report of LLR for malignancy was
published soon after that in 1994.7 These early reports demon-
strated the feasibility of LLR, and since then an estimated 3000R.M. and A.H.M. contributed equally to this study.
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cases of LLR have been performed worldwide for varying indica-
tions including hepatocellular carcinoma (HCC), colorectal cancer
metastases (CRCM) and various benign pathologies.8
Nevertheless, there remain a number of concerns regarding LLR.
Liver mobilization and parenchymal transection can be difficult
laparoscopically, and achieving control of haemorrhage can also
present a significant challenge.9,10 Furthermore, there is the theo-
retical risk of gas embolism during division of the hepatic veins
under pneumoperitoneum.11 The arduous learning curve and con-
cerns regarding the ease with which the necessary skills can be
disseminated amongst liver surgeons constitute further reserva-
tions. These technical considerations aside, there remains uncer-
tainty regarding the adequacy of oncological resection with LLR
when compared with conventional open liver resection (OLR) for
cancer. To date, no randomized-controlled trials (RCT) have
addressed this question,and these issues combinedhavemeant that
widespread adoption of LLR has been slow to gain momentum.
A recent Consensus Conference (November 2008, Louisville,
Kentucky, USA) aimed to address some of these concerns and
attempted to define more clearly the role of LLR in surgical prac-
tice.12 The Consensus Statement suggested that an RCT would be
valuable,however, therewas recognitionof theprobable difficulties
with the required study population size and lengthy study dura-
tion. Until a prospective trial is undertaken, outcome comparison
between LLR and OLR is entirely contingent upon data from
available case–control series.A previously publishedmeta-analysis
evaluated short-term outcomes in a small number of studies com-
paring LLR andOLR,13 but since that timemanymore studies have
been published, meaning that comparison can now also be drawn
with regard to long-term outcomes, including cancer-specific
recurrence rate and survival. The present study is a meta-analysis
updating peri-operative outcomes for benign and malignant con-
ditions, and for the first time, reporting on survival and recurrence
rates for malignant pathology with LLR vs. conventional OLR.
Methods
Study selection
Two authors (R.M and A.H.M) independently carried out elec-
tronic literature searches using MEDLINE (1950 to August 2009),
EMBASE (1980 to August 2009), CINAHL (1982 to August 2009)
and the Cochrane library to identify studies comparing LLR and
OLR. The following medical subject heading (MeSH) terms and
key words were used: ‘laparoscopic liver resection’, ‘laparoscopic
hepatic resection’, ‘Laparoscopic hepatectomy’ and ‘laparoscopic
vs. open’. The ‘related articles’ function was used to broaden the
search and all abstracts, studies and citations retrieved were
scanned. Reference lists of all relevant publications were then
hand searched for additional studies missed by the search strategy,
and this method of cross-referencing was continued until no
further relevant publications were identified. The latest date on
which a literature search was undertaken was 20th December 2009
(Fig. 1).
Study inclusion criteria and data extraction
A study methodology was carried out in accordance with the
‘Preferred Reporting Items for Systematic Reviews and Meta-
Analyses’ (PRISMA) recommendations for improving the
standard of meta-analyses.14 In order to be included in the meta-
analysis, studies had to report on peri- and post-operative out-
comes when comparing LLR and OLR. Only studies published in
the English language were included. Where multiple studies
describing the same patient population were identified, the most
recent publication was used. In cases of doubt, the authors were
contacted for further information to ensure accuracy.Where there
was disagreement over eligibility of a study, an additional reviewer
(K.C.) assessed the article until a consensus was reached. Two
reviewers (R.M. and A.M.) independently extracted the following
data from all eligible studies according to a pre-specified protocol:
first author, year of publication, study population characteristics,
study design, number of subjects operated on, number of laparo-
scopic cases, number of open cases, matching criteria between
laparoscopic and open patient groups, indication for surgery, type
of liver resection performed and use of adjuvant chemotherapy.
The following outcome parameters were extracted for comparison
by meta-analytical assessment: operation duration, estimated
blood loss, need for portal triad clamping, portal triad clamping
time, length of hospital stay, time to resumption of oral diet,
30-day mortality rate, resection margin status, rate of resection
margin <1 cm, rate of positive resection margin, overall and liver-
specific complication rate(s), hepatic tumour recurrence (stating
where available whether hepatic recurrence was at a site of previ-
ous resection, or remote), extra-hepatic tumour recurrence,
overall disease-free survival (DFS) and cost.
Assessment of methodological quality and validity
Having met the inclusion criteria, studies were subjected to an
assessment ofmethodological quality and validity by two reviewers
(R.M. and A.H.M.) and graded on strength of evidence using the
revised grading system of the Scottish Intercollegiate Guidelines
Network (SIGN).15 In the event of a discrepancy in assigned grade,
studies were re-evaluated until consensus was reached.
Statistical analysis
Statistical analysis was performed using MedCalc for Windows,
version 11.3 (MedCalc software, Mariakerke, Belgium). For cat-
egorical data, the odds ratio (OR)was calculated using theMantel–
Haenszel method,16 and for continuous data the standardized
mean difference (SMD) was calculated with Cohen’s d method.17
The results are providedwith corresponding 95%confidence inter-
vals (CI) and P-values; results were deemed significant at P < 0.05.
Additionally the finding of a SMD >0.5 or <-0.5 was considered
indicative of a medium effect size (Cohen’s rule of thumb17).
Heterogeneity was examined using the Q statistic18 and quan-
tified with I2. Statistical significance was fixed at 0.10 rather than
the conventional level of 0.05 for heterogeneity because of the low
power of this test.19 Heterogeneity was rejected if P was greater
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than 0.10. When there was significant heterogeneity, the
DerSimonian–Laird random effect model (REM)20 was used to
calculate summary effect size while the fixed effect model (FEM)
was used when there was no heterogeneity.
Publication bias was identified visually looking for asymmetry
in Begg’s funnel plots, that is, plots of effect size against their
precision (inverse of standard error) for continuous data and
effect size against sample size for categorical data.21 The degree of
asymmetry in funnel plots was assessed using Egger’s regression
analysis.22 Funnel plots were considered symmetrical if the 95%CI
of the intercept (a) of Egger’s regression crossed zero.
Results
Literature search and description of studies
The predefined search strategy identified 229 potentially relevant
publications. After screening titles and abstracts, 202 publications
were excluded, comprising 14 review articles and 188 publications
that did not meet inclusion criteria or were found to be non-
comparative. Full text articles for the remaining 27 studies were
retrieved and reviewed in detail. Examination of references from
these 27 studies did not reveal any additional relevant publica-
tions. Duplicated data were identified in one publication and this
was excluded from analysis.23 In total, 26 studies, published
between 1998 and 2009 met the a priori determined inclusion
criteria and were entered into the meta-analysis. Study character-
istics are summarized in Tables 1 and 2.
The combined population from included studies was 1678
(range 20–179). A laparoscopic resection was performed in 717
patients (43%) and an open resection in 961 (57%). The indica-
tion for resection was malignant disease in 445 out of 717 cases of
LLR (62%) compared with 628 out of 961 cases of OLR (65%). Of
the 445 cases of malignant disease in the LLR group, 267 were for
HCC, 142 were for CRCM and 36 were for other malignancies. All
studies included in the meta-analysis provided comparative data
for LLR vs. OLR for benign and malignant disease. One study
involved prospective data collection for both groups (evidence
level 3).38 In 12 studies, prospective LLR cases were compared
with retrospective matched OLR cases24–26,28,29,31,33,34,36,39,43,46 (evi-
dence level 3). Retrospective data collection and matching for
both LLR and OLR was conducted in a further 12
studies27,30,32,35,37,40,41,44,45,47–49 (evidence level 3). In one study the
laparoscopic cohort consisted of 25 prospective and 6 retrospec-
tive cases compared with a retrospective matched OLR cohort42
(evidence level 3).
The cumulative reported conversion-to-open rate for all
laparoscopic procedures was 7% (50 out of 717). Outcome
data comparing converted cases with purely laparoscopic or
open cases were not described in any study included in this
meta-analysis.
Thirty-day mortality occurred in 0.6% of patients undergoing
LLR (4 out of 717) compared with 1% of patients undergoing
OLR (10 out of 961). The reported incidence of gas embolism
with LLR was 0.1% (1 out of 717).46 There were no reported cases
of port-site recurrence after LLR for malignant disease.
Selection criteria for LLR
Seven studies did not provide any clearly described selection cri-
teria for LLR.24,27,30–32,38,40 The remaining studies described heter-
ogenous selection methods for LLR. Irrespective of the indication
for surgery, the twomost frequently reported inclusion criteria for
LLR were a tumour 5 cm in size25,28,29,36,42 for malignant
lesions45,49 and tumours involving the left and/or antero-lateral
Couinaud segments (that is 2, 3, 4, 5, or 6).25,28,29,35–37,42,45,49 Other
stipulated selection criteria were: only benign tumours,26,35 first-
time liver resection,25,47,48 only patients with non-cirrhotic liver or
Child’s A or B stage cirrhosis,39,41,46,47 a tumour involving 2 seg-
ments,34,44 a tumour 8 cm42 for benign lesions,46 a tumour
12 cm,33 American Society of Anesthesiologists (ASA) grade
2,35 ASA grade 3 and41,46 a tumour not associated with major
vascular/biliary involvement.41,44,46 Of note, body mass index
(BMI) was not outlined as an independent inclusion/exclusion
condition in any of the studies.
Meta-analysis results
Operative parameters for benign and malignant disease
Seventeen studies,24,26,28,29,32–35,39–43,45,46,48,49 comprising 1023
patients, provided data on operation duration (Fig. 2). Median
operation times for laparoscopic cases were 220 (range 161–
362 min) and 204 min (range 128–366 min) for open surgery.
Pooled analysis demonstrated that operation duration was signifi-
cantly longer in LLR compared with OLR (Table 3; SMD = 0.536;
95%CI = 0.120 to 0.952; P = 0.012), although significant between-
study heterogeneity was observed (P < 0.001).
Data regarding estimated blood loss were available in 15
studies,24,26,28–30,32–34,39,41–43,45,46,49 with a combined population of 847
patients (Fig. 3). The median blood loss was 320 ml for LLR
(range 122–620 ml) and 483 ml for OLR (range 214–895 ml).
Meta-analytical assessment of the pooled data showed signifi-
cantly reduced blood loss with LLR compared with OLR (Table 3;
SMD = -1.109; 95% CI = -1.549 to -0.669; P < 0.001), although
again significant study heterogeneity was noted.
Twelve studies, including 847 patients, evaluated the need for
portal triad clamping.27–30,34,35,41,44,46–49 Meta-analysis demonstrated
a significantly lower rate of portal triad clamping in LLR com-
pared with OLR (Table 3; OR = 0.211; 95% CI = 0.091 to 0.491;
P = 0.003), and significant heterogeneity was observed between
these studies (P < 0.001). Additionally, comparative data on dura-
tion of vascular pedicle clamping were available in three of these
studies,28,29,35 and meta-analysis found no significant difference in
clamping duration (where required) between LLR and OLR
(Table 3; SMD = 0.907; 95% CI = -0.658 to 2.472; P = 0.255).
Sensitivity analyses were conducted to exclude studies with large
effect sizes and wide 95% CI; however, it was not possible to
eliminate the observed heterogeneity.
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Post-operative parameters for benign and
malignant disease
Data regarding the overall complication rate were available in 25
studies24–30,32–49 which included 1561 patients (Fig. 4). Meta-
analysis showed significantly fewer overall complications after LLR
comparedwithOLR (Table 3;OR= 0.452; 95%CI= 0.345 to 0.590;
P < 0.001). This finding was not associated with significant study
heterogeneity. Liver-specific complications (including all cases of
Table 1 Summary table of characteristics of studies comparing outcomes after laparoscopic vs. open liver resection (all studies – evidence
grade 3)
Author Year Location Study type No. Lap/
Open
Matching criteria Indication for surgery Evidence
grade
Rau et al.24 1998 Germany CM; L(P) O(R) 34 17/17 a, b, h, k, l B (L15 O15); M (L2 O2)a 3
Shimada et al.25 2001 Japan CM; L(P) O(R) 55 17/38 a, b, e, f, h(i), k-n, p M (L17 O38)b 3
Farges et al.26 2002 France CM; L(P) O(R) 42 21/21 a, b, d, i, k, l, n B (L21 O21) 3
Mala et al.27 2002 Norway CM; L(R) O(R) 27 13/14 a-c, h(ii), j-m M (L13 O14)a 3
Laurent et al.28 2003 France CM; L(P) O(R) 27 13/14 a, b, e-g, h(i), k, l, n M (L13 O14)b 3
Lesurtel et al.29 2003 France CM; L(P) O(R) 38 18/20 a-c, e, h, i, l, n B (L12 O13); M (L6 O7)§ 3
Morino et al.30 2003 Italy CM; L(R) O(R) 60 30/30 a-c, e, k, l, n B (L16 O5); M (L14 O25)c 3
Buell et al.31 2004 USA CM; L(P) O(R) 117 17/100 l, m B (L12 O n.a); M (L5 O n.a)d 3
Kaneko et al.32 2005 Japan CM; L(R) O(R) 58 30/28 a, b, f, g, h(i), k, l, n M (L30 O28)b 3
Aldrighetti et al.33 2008 Italy CM; L(P) O(R) 40 20/20 a, b, e, f, l, n, p B (L5 O5); M (L15 O15)e 3
Polignano et al.34 2008 UK CM; L(P) O(R) 50 25/25 a-c, e, k, l-n B (L4 O2); M (L21 O23)f 3
Troisi et al.35 2008 Belgium CM; L(R) O(R) 40 20/20 a-d, i, k, l, n B (L20 O20) 3
Lee et al.36 2008 Hong Kong CM; L(P) O(R) 50 25/25 a-c, e, g, j-n, p B (L6 O2); M (L19 O23)g 3
Abu Hilal et al.37 2008 UK CM; L(R) O(R) 44 24/20 a, b, h(i, ii, iii), i, n B (L7 O5); M (L17 O15)h 3
Topal et al.38 2008 Belgium CM; L(P) O(P) 152 76/76 a, c, e, h(i, ii), i, k, l, n, o n.a 3
Cai et al.39 2009 China CM; L(P) O(R) 38 19/19 a, b, f-i, k, l, n B (L18 O18)i; M (L1 O1)j 3
Sarpel et al.40 2009 USA CM; L(R) O(R) 76 20/56 a, b, e, h(i), l M (L20 O56)b 3
Tranchart et al.41 2009 France CM; L(R) O(R) 84 42/42 a-c, e-g, h(i), l, n M (L42 O42)b 3
Tsinberg et al.42 2009 USA CM; L(25P 6R) O(R) 74 31/43 a, b, k, l, n B (L17 O12); M (L14 O31)k 3
Rowe et al.43 2009 Canada CM; L(P) O(R) 30 18/12 a, b, e, g, h(i,ii, iii), i, n B (L4 O1); M (L14 O11)l 3
Ito et al.44 2009 USA CM; L(R) O(R) 130 65/65 a, b, d, e, h(i, ii, iii), i, l-n B (L28 O18); M (L37 O47)m 3
Endo et al.45 2009 Japan CM; L(R) O(R) 21 10/11 b, e, g, h(i), l-n M (L10 O11)b 3
Dagher et al.46 2009 France CM; L(P) O(R) 72 22/50 a-h(i, ii, iii), i, k, l, n, o B (L7 O14); M (L15 O36)n 3
Carswell et al.47 2009 UK CM; L(R) O(R) 20 10/10 a-c, h, i, n B (L4 O6); M (L6 O4)o 3
Castaing et al.48 2009 France CM; L(R) O(R) 120 60/60 a, b, h(ii), k-m, o M (L60 O60)a 3
Belli et al.49 2009 Italy CM; L(R) O(R) 179 54/125 a-c, e, g, h(i), k, m M (L54 O125)b 3
CM, comparative matched; L, laparoscopic; P, prospective; O, open; R, retrospective; B, benign disease; n.a, not available; M, malignancy; HCC,
hepatocellular carcinoma.
Matching criteria: (a) age (b) gender (c) ASA grade (d) BMI (e) liver cirrhosis (f) pre-operative liver function tests (g) Child-Pugh score (h) malignant
disease (i) HCC (ii) colorectal metastases (iii) other (i) benign disease (j) previous liver resection (k) location of lesion (l) size of lesion (m) number of
lesions (n) type/extent of resection (o) adjuvant chemotherapy (p) histology.
§Matched cases of LLR and OLR for HCC, CRCM and breast metastases.
aCRCM in all cases.
bHCC in all cases.
cCRCM-14 (L5 O9), other metastases-9 (L5 O4); HCC-12 (L3 O9), gallbladder cancer-3 (L0 O3), lymphoma-1 (L1 O0).
dMetastases-1, lymphoma-1, HCC-3.
eUnspecified metastases-14 (L7 O7); HCC-16 (L8 O8).
fCRCM-36 (L16 O20), HCC-6 (L4 O2), gallbladder cancer-2 (L1 O1).
gHCC-32 (L16 O16), CRCM-8 (L3 O5), intra-hepatic cholangiocarcinoma-1 (L0 O1), other-1 (L0 O1).
hHCC-3 (L2 O1), CRCM-29 (L15 O14).
iOne patient with presumed benign disease (hepatolithiasis) in laparoscopic group was found intra-operatively to have cholangiocarcinoma (resected).
jLiver cancer (unspecified)-2 (L1 O1).
kHCC-17 (L4 O13), CRCM-25 (L9 O 16), other-3 (L1 O2).
lHCC-13 (L9 O4), unspecified metastases-12 (L5 O7).
mHCC-17 (L12 O15), unspecified metastases-57 (L25 O32).
nHCC-14 (L4 O10), CRCM-33 (L10 O23), other-4 (L1 O3).
oCRCM-8 (L6 O2), HCC-1 (L0 O1), Leiomyosarcoma-1 (L0 O1).
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biliary leak/collection, bleeding and post-operative abscess
formation) were reported in 19 studies,24–30,32–46,48 including 1060
patients. Meta-analysis demonstrated a significant difference in
the incidence of liver-specific complications with LLR
compared with OLR (Table 3; OR = 0.636; 95% CI = 0.422 to
0.960; P = 0.012) with no significant between study heterogeneity.
Length of stay (LOS) was examined, assessing 1009 patients
(Fig. 5).24–26,28–33,35,39,41–43,45,46,49 Median LOS for LLR was 8 days
(range 3–20 days), and 10 days with OLR (range 6–32 days).
Duration of hospital stay was significantly shorter after LLR com-
paredwithOLR (Table 3;OR= -1.109; 95%CI = -1.549 to -0.669;
P < 0.001). One study assessed the adjusted odds of LOS 6 days
and found this to be significantly lower in patients undergoing
LLR.40 None of the studies described the use of a specific enhanced
recovery after the surgery programme for either LLR or OLR.Data
on time to resumptionof diet after LLR andOLRwere compared in
5 studies evaluating 245 patients.26,32,35,42,45 Results favoured LLR for
earlier return to oral dietary intake (Table 3; OR = -2.651; 95% CI
= -4.532 to -0.770; P = 0.006), with significant between study
heterogeneity (P < 0.001). Sensitivity analyses eliminated the
observed heterogeneity (by exclusion of one outlying study42) and
although this reduced the SMD to -0.995 (95% CI = -1.412 to
-0.601), statistical significance was retained (P = 0.005).
Resection margin outcomes for LLR vs. OLR for all cases
of malignant disease
Data on the surgical resection margin were available in eight
studies, comprising 392 patients.25,28,33,41,42,45,46,48 Meta-analysis of
Table 2 Data on type of resection, laparoscopic conversion rates, mortality and adjuvant therapy from included studies
Author Procedures performed Conversion 30-day
mortality
Adjuvant
therapy
Rau et al.24 NAR (L2 O2) S (L7 O4) BiS (L8 O10) TriS (L0 O1) 1/17 (6%) NA NA
Shimada et al.25 NAR (L10 O na) LLS (L7 O na) a NA NA NA
Farges et al.26 NAR (L9 O9) S (L4 O4) BiS (L8 O8) NA NA NA
Mala et al.27 NAR (L11 O10) LLS (L2 O4) NA NA L0 O1
Laurent et al.28 NAR (L3 O4) S (L7 O7) BiS (L3 O3) 2/13 (15%) L (0) O (2) TACE (L2 O2)
Lesurtel et al.29 LLS (L18 O20) 2/18 (11%) NA NA
Morino et al.30 NAR (L5 O5) S (L12 O12) BiS (L13 O13) NA NA nana
Buell et al.31 S (L4 O n.a) BiS (L5 O n.a) TriS (L4 O na) LLS (L7 O na) RL (L1 O na) NA L(1) O (n.a) Na
Kaneko et al.32 PH (L20 O20) LLS (L10 O8) 1/30 (3%) NA nana
Aldrighetti et al.33 LLS (L20 O20) NA NA nana
Polignano et al.34 NAR (L5 O6) S (L4 O5) BiS (L6 O5) LLS (L10 O9) 2/25 (8%) NA NA
Troisi et al.35 NAR (L7 O6) S (L5 O5) BiS (L6 O4) LLS (L1 O3) LHH (L2 O1) 2/20 (1%) NA nana
Lee et al.36 NAR (L16 O15) LLS (L11 O11) 2/25 (8%) NA NA
Abu Hilal et al.37 LLS (L24 O20) NA NA NA
Topal et al.38 Na 7/76 (9%) NA NA
Cai et al.39 LHH (L19 O19) 2/19 (11%) NA NA
Sarpel et al.40 Na a b NA
Tranchart et al.41 NAR (L10 O10) S (L15 O13) BiS (L3 O7) LLS (L9 O7) LHH (L 2 O2)
RHH (L3 O3)
2/42 (5%) L(1) O(1) NA
Tsinberg et al.42 S (L23 O28) BiS (L23 O28) NA NA NA
Rowe et al.43 S (L17 O11) BiS (L0 O1) LHH (L1 O0) 1/18 (6%) NA NA
Ito et al.44 NAR (L26 O28) S (L49 O47) BiS (L16 O18) LLS (L11 O9) RPS (L1 O1) 13/65 (20%) NA NA
Endo et al.45 LLS (L10 O11) NA NA NA
Dagher et al.46 RHH (L22 O50) 2/22 (9%) L(0) O(1) NA
Carswell et al.47 LLS (L10 O10) 1/10 (10%) NA NA
Castaing et al.48 NAR (L18 O8) S (L6 O16) BiS (L5 O9) LHH (L1 O2) RHH (L23 O18)
CH (L1 O1) LL (L6 O6)
6/60 (10%) L(1) O(1) L34 O34
Belli et al.49 3 segments (L3 O39)
2 segments (L51 O86)
4/54 (7%) L(1) O(5) TACE (L5);
SC (L1)
L, lapropscopic; O, open; NAR, non-anatomical resection; S, segmentectomy; BiS, bisegmentectomy; LLS, left lateral sectionectomy; HCC,
hepatocellular carcinoma; TACE, transarterial chemo-embolization; TriS, trisegmentectomy; RL, right lobectomy; LHH, left hemihepatectomy; RHH,
right hemihepatecfomy; RPS, right posterior sectionectomy; SC, systemic chemotherapy; CH, central hepatectomy; LL, left lobectomy.
aFour cases converted to open but not included in study.
bOne per-operative death but unclear whether in laparoscopic or open group, NA not available.
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pooled data did not find any significant difference in the size of the
resection margin with LLR compared with OLR (Table 4; OR =
-0.356; 95%CI = -1.061 to 0.349;P = 0.318). Six studies compared
the incidence of a resection margin <1 cm in size with LLR and
OLR, evaluating a total of 269 patients.27–31,49 Meta-analysis of this
data showed an increased incidence of a resectionmargin <1 cm in
OLR (Table 4; OR = 0.511; 95%CI = 0.293 to 0.893; P = 0.03), with
no significant between study heterogeneity. Involvement of the
resectionmargin was evaluated between LLR andOLR in 8 studies
on 591 patients.25,27,31,35,41,42,48,49 Resection margin positivity was
greater inOLR than LLRwith no significant between study hetero-
geneity (Table 4; OR = 0.524; 95% CI = 0.296 to 0.927; P = 0.026).
Recurrence and survival outcomes after LLR vs. OLR for
malignant disease
Eleven studies provided oncological data on LLR vs. OLR
for CRCM, with a combined number of 212
patients.24,27,29,30,33,35,37,42,46–48 However, these data were not suitable
for meta-analytical evaluation as outcomes for CRCM were pre-
sented alongside other cancer types with no clear distinction of
results based on histology. Only three studies evaluated CRCM
only,25,28,47 of which only one provided oncological outcome data.47
For HCC, data on hepatic tumour recurrence were available
from four studies comparing LLR and OLR, with a cumulative
study population of 366 patients (Fig. 6).28,40,41,49 A distinction
between hepatic recurrences that were local to the resection site
compared with distant hepatic recurrences was only made in two
of these studies. Laurent and co-workers found all hepatic recur-
rences were remote to the site of surgery.28 Tranchart et al.41
reported tumour recurrence at the site of a previous resection in 2
cases of LLR and one case of OLR out of a total study population
of 84.Meta-analysis of pooled data demonstrated no difference in
the rate of hepatic tumour recurrence after LLR vs. OLR for HCC
(Table 4; OR = 0.832; 95% CI = 0.527 to 1.314; P = 0.430).
Data on the extra-hepatic recurrence rate in HCC were avail-
able from four studies, but were unsuitable for meta-
Table 3. Results of meta-analyses for peri-operative outcome measures after laparoscopic liver resection (LLR) vs. open liver resction (OLR)
Peri-operative outcomes Number
of studies
Patients Lap/Open SMD/OR (95% C.I) P-value Study heterogeneity
I2 Q DF P-value
Operation duration 17 1023 440/583 0.536 (0.120, 0.952)a 0.012 89.3% 150.17 16 <0.0001
Estimated blood loss 15 847 370/477 -1.109 (-1.549, -0.669)a <0.0001 90.9% 153.85 14 <0.0001
Portal triad clamping 12 847 372/475 0.211 (0.091, 0.491)b 0.003 68.9% 35.41 11 <0.0001
Portal triad clamping time 3 105 51/54 0.907 (-0.658, 2.472)a 0.255 92.4% 26.18 2 <0.0001
Length of stay 17 1009 399/610 -1.109 (-1.549, -0.669)a <0.0001 89.0% 144.94 16 <0.0001
Time to resumption of diet 5 245 112/133 -2.651 (-4.532, -0.770)a 0.006 96.7% 122.94 4 <0.0001
Overall complication rate 25 1561 700/861 0.452 (0.345, 0.590)b <0.0001 13.8% 27.83 24 0.267
Liver specific complication rate 19 1060 498/562 0.636 (0.422, 0.960)b 0.012 9.0% 19.78 18 0.345
Lap, laparoscopic; SMD, standardized mean difference; OR, odds ratio; I2, index used to measure the extent of study heterogeneity in meta-analysis;
Q, statistic used to assess for study heterogeneity in meta-analysis; DF, degrees of freedom.
aSMD with 95% CI.
bOR with 95% CI.
Table 4. Results of meta-analyses for resection margin status, recurrence rate and survival after laparoscopic liver resection (LLR) vs. open
liver resction (OLR) for cases of malignant disease
Pathological and
oncological outcomes
Number
of studies
Patients Lap/Open SMD/OR (95% CI) P-value Study heterogeneity
I2 Q DF P-value
Studies comparing resection margin status for LLR vs. OLR for all types of malignant disease
Resection margin (mm) 8 392 215/177 -0.356 (-1.061, 0.349)a 0.318 89.9% 69.41 7 <0.0001
Resection margin <1 cm 6 351 138/213 0.511 (0.293, 0.893)b 0.030 13.5% 5.77 5 0.328
Resection margin positive 8 591 250/341 0.524 (0.296, 0.927)b 0.026 0.00 5.56 7 0.591
Studies comparing long-term outcome with LLR vs. OLR for HCC only
Hepatic recurrence rate 4 366 129/237 0.832 (0.527, 1.314)b 0.430 0.00 0.64 3 0.887
Disease-free survival 6 424 166/258 0.990 (0.605, 1.621)b 0.969 0.00 1.88 5 0.864
Overall survival 7 500 186/314 1.500 (1.002, 2.246)b 0.049 0.00 3.62 6 0.728
Lap, laparoscopic; SMD, standardized mean difference; OR, odds ratio; I2, index used to measure the extent of study heterogeneity in meta-analysis;
Q, statistic used to assess for study heterogeneity in meta-analysis; DF, degrees of freedom.
aSMD with 95% CI.
bOR with 95% CI.
300 HPB
HPB 2011, 13, 295–308 © 2011 International Hepato-Pancreato-Biliary Association
analysis.42,44,48,49 DFS results for HCC were extracted from six
studies on 424 patients (Fig. 8),25,28,32,41,45,49 and showed no differ-
ence in DFS when comparing LLR and OLR (OR = 0.990; 95%
CI = 0.605 to 1.621; P = 0.969), with significant between study
heterogeneity (Table 4). Seven studies, assessing 500 patients,
provided data on overall survival (OS) after LLR compared with
OLR for cases of HCC only (Fig. 7).25,28,32,40,41,45,49 Meta-analysis
showed a tendency towards increased OS after LLR compared
with OLR (OR = 1.50; 95% CI = 1.002 to 2.246; P = 0.049) with no
significant between study heterogeneity (Table 4).
Cost outcomes following LLR versus OLR
Data on cost outcomes were limited to two studies and were not
suitable for meta-analysis.34,42 Polignano et al. reported increased
disposable instrument costs with LLR compared with OLR.
However, these expenses were offset by reduced high dependency
unit (HDU) and ward stay costs, meaning that total costs were
significantly lower with LLR.34 Similarly Tsinberg et al. also
reported significantly reduced hospital and overall costs with LLR
compared with OLR.42
Discussion
Minimally invasive surgery (MIS) has revolutionized surgical
practice over the past 30 years. Advances in both technique and
technology have allowed the laparoscopic approach to be applied
229 publications identified through database search and screened
202 studies excluded after screening titles and abstracts
27 full text articles retrieved and assessed for eligibility
1 study excluded for duplicated data
26 studies included in meta-analysis
•     14 reviews
•     188 non-comparative or irrelevant studies
Figure 1 Modified PRISMA flow diagram showing study methodol-
ogy
Study
Rau et al. 17 184 55 17 128 37 1.195 (0.46,1.93)
13 267 79 14 182 57 1.242 (0.41,2.07)
18 202 38 20 145 31 1.653 (0.91,2.40)
20 260 50 20 220 30 0.970 (0.31,1.62)
20 220 122 20 214 97 0.054 (0.32,–0.57)
19 222 104 19 204 59 0.213 (0.33,–0.43)
42 233 92 42 221 46 0.165 (0.22,–0.26)
31 201 15 43 172 12 2.175 (0.30,1.59)
22 360 20 50 328 10 2.322 (0.32,1.69)
20 161 37 56 165 53 –0.081 (0.26,–0.59)
18 135 33 12 138 42 –0.082 (0.37,–0.81)
60 278 123 60 294 89 –0.149 (0.18,–0.51)
54 167 36
Test for heterogeneity: H = 3.06; Q = 150.17; d.f. = 16; P < 0.0001; I2 = 89.3 Favours LLR Favours OLR
125 185 61 –0.329 (0.16,–0.65)
0.536 (0.12,0.95) (100)
–1 0 1 2 3
10 265 50 11 230 65 0.600 (0.45,–0.27)
21 177 57 21 156 42 0.419 (–0.19,1.03)
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25 362 113 25 366 73
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Figure 2 Pooled estimates of procedure duration for laparoscopic liver resection (LLR) vs. open liver resction (OLR). The solid squares
denote individual standardized mean differences (SMD) and the horizontal lines represent 95% confidence intervals (CI). The diamonds
denote overall pooled SMD
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to increasingly complex surgical procedures. LLR has been slow to
gain acceptance, but is now gradually becoming an established
part of international practice. Widespread implementation has
been hindered by a number of factors. Perceived hazards include
gas embolism, port-site tumour recurrence and impaired ability
to control bleeding. Furthermore, LLR is technically challenging
with a long learning curve, hence dissemination of skills and
training has been difficult. Finally, making a strong case for
routine LLR for liver tumours has been difficult as long-term data
has been lacking, and the adequacy of oncological resection com-
pared with OLR has been questioned.
To date, close to 3000 cases of LLR have been reported in the
literature,8 although high-quality evidence is scarce. No random-
ized trials have been undertaken comparing LLRwith OLR, and so
the assumed benefits of a laparoscopic approach remain
unproven. In 2007, Simillis et al. performed a meta-analysis of
case-matched studies up to 2005 examining short-term outcomes
with LLR compared with OLR.13 Although limited to only eight
studies, this meta-analysis demonstrated favourable short-term
outcomes with LLR. No long-term data were evaluated however.
Since then, a further 18 studies have been published comparing
LLR with OLR, and intermediate and long-term data are now
available for analysis. The present study provides an up-to-date
summary of the evidence comparing outcomes after LLR and
OLR. In particular, the study is the first to provide meta-analytical
evaluation of pathological, and in the case of HCC, oncological
outcomes achieved with LLR and OLR.
Twenty-six studies met predefined inclusion criteria and were
entered into the meta-analytical process, providing a total of 1678
liver resections. In all, 717 (43%) procedures were attempted lap-
aroscopically with a conversion rate of 7%. With respect to peri-
operative outcomes, LLR takes significantly longer to perform
compared with conventional open surgery. In keeping with trends
observed in other sub-specialties, it is likely that as experience
with LLR increases, procedure duration will shorten. Indeed it is
even conceivable that in the future LLR may take less time than
OLR, as the latter involves larger, more time-consuming incisions.
It is worth noting that contrary to our findings, Simillis et al.
found no increase in operating time with LLR.13 One possible
explanation is that more difficult laparoscopic procedures are now
being attempted, accounting for increased procedure duration.
This suggestion is supported by the fact that the studies evaluated
by Simillis et al. included only one laparoscopic right hepatectomy
(0.6%), compared with 49 laparoscopic right hepatectomies
included in the present analysis (7%). On a cautionary note, the
validity of LOS as a comparative outcome measure is frequently
questioned, as it can be influenced by factors often entirely dis-
connected from the surgical intervention. In this respect, the
Study
Rau et al. 17 458 343 17 556 384 –0.269 (–0.95,0.41)
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Figure 3 Pooled data of estimated blood loss for laparoscopic liver resection (LLR) vs. open liver resction (OLR)
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authors acknowledge that data on discharge criteria would be a
useful addition to the data presented here, although these data
were found to be consistently lacking from the included studies.
The present study also finds superior short-term outcomes
including reduced blood loss, fewer overall complications, fewer
liver-specific complications, shortened LOS and earlier resump-
tion of oral intake after LLR compared with OLR. This is consis-
tent with data on other laparoscopic abdominal procedures,5 and
more recent work conducted by our group adds further weight to
this data.50
The issue of haemorrhage warrants particular attention as
intra-operative bleeding during liver parenchymal transection is
of great concern, with a reported incidence of 7% in the litera-
ture.51 Early studies demonstrated that LLR results in reduced
blood loss after minor liver resections30 and left lateral sectionec-
tomies.29 However, it has been unclear if this finding would also
apply to more complex resections. Dagher et al. recently reported
on outcomes in closely matched patients undergoing right hepa-
tectomy. In their study of 72 patients, they found blood loss
to be reduced with LLR compared with OLR (519  93 ml and
735  74 ml, respectively; P = 0.038).46 Although few surgeons
would counsel against conversion in the face of major haemor-
rhage, the increasingly sophisticated array of laparoscopic equip-
ment available for the control of bleeding may be supporting
more complex surgery, a view reiterated in a recent multi-national
consensus conference examining the role of LLR.12
The present study provides the first pooled analysis of onco-
logical outcomes in LLR, and a total of 1073 cancers were identi-
fied in the literature. LLR can achieve equivalent resection
margins compared with OLR. In fact, LLR was associated with a
lower incidence of margin involvement and a margin <1 cm. A
possible explanation for this finding is that more challenging
oncological resections with concerns regarding margin positivity
and proximity of major vascular and/or biliary structures are still
performed using an open approach. Consistent with this, selection
criteria for LLR, where stated, included smaller and anatomically
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Figure 4 Pooled estimates of overall complication rate for laparoscopic liver resection (LLR) vs. open liver resction (OLR). The solid squares
denote individual odds ratio (OR) and the horizontal lines represent 95% confidence intervals (CI). The diamonds denote overall pooled OR
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easier lesions, with no re-operative cases, and although matching
criteria were frequently adopted in the studies examined
(Table 1), not all reports examined here matched for tumour size
and type of resection.
In relation to survival and recurrence rates, CRCM and HCC
should be considered separately. The publications included in the
present study incorporate 212 resections for CRCM; however,
these data were not suitable for meta-analysis. In the currently
available literature, data on LLR for CRCM are therefore largely
reliant on data from non-comparative studies. Nguyen et al.
reported oncological outcomes from a large multi-institutional
cohort of patients undergoing LLR for CRCM and found that
Study WeightSMD (95% CI) SMD (95% CI)
LLR
MeanN SD
OLR
MeanN SD
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Figure 5 Pooled estimates of length of hospital stay for laparoscopic liver resection (LLR) vs. open liver resction (OLR). The solid squares
denote individual standardized mean differences (SMD) and the horizontal lines represent 95% confidence intervals (CI). The diamonds
denote overall pooled SMD
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Figure 6 Pooled estimates of hepatic recurrence rate after laparoscopic liver resection (LLR) vs. open liver resction (OLR) for hepatocellular
carcinoma (HCC). The solid squares denote individual odds ratios (OR) and the horizontal lines represent 95% confidence intervals (CI). The
diamonds denote overall pooled OR
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resection margin status and overall 5-year survival were compa-
rable with data from contemporary open series.8 Well-conducted
randomized studies are necessary to specifically address this
question.
With respect to HCC, relatively more data are available and we
identified seven studies reporting comparative oncological
outcome data for LLR and OLR.25,28,32,40,41,45,49 Meta-analysis of
these data indicates an equivalent hepatic recurrence rate with
laparoscopic and open resection. A significant trend towards
improved OS after LLR was noted (P = 0.049), although no sig-
nificant difference was found for DFS. This parity would seem
logical, and yet there are emerging data, to suggest that MIS may
be oncologically superior to conventional open surgery; experi-
mental studies have shown that open surgery results in increased
systemic levels of circulatory cytokines and vascular endothelial
growth factor (VEGF) compared with laparoscopy; these pro-
inflammatory biomarkers have been implicated in tumour
growth, survival and proliferation.52 In addition, enhanced recov-
ery and reduced post-operative complications after laparoscopic
surgery may facilitate early institution of adjuvant therapy, which
may also improve cancer outcomes.
Special mention is warranted in the case of cirrhotic patients
undergoing OLR for HCC, where post-operative ascites and
hepatic decompensation can pose significant difficulties. As the
abdominal wall is relatively spared from injury in LLR, this may
reduce any loss of collateral venous circulation when compared
Events Subjects Events Subjects
LLR OLR
)84.5,35.0(907.1
)16.98,09.0(000.9
)87.2,43.0(179.0
)90.21,05.0(554.2
)48.3,86.0(816.1
)86.6,22.0(002.1
)06.2,86.0(333.1
)52.2,00.1(005.1
201.0
130.0
741.0
460.0
812.0
550.0
463.0
Study WeightOR (95% CI) OR (95% CI)
Shimada et al.
Farges et al.
Kancko et al.
Sarpel et al.
Tranchart et al.
Endo et al.
Belli et al.
Overall effect
(REM)
P = 0.049
8
12
18
18
25
6
83
41
82
65
24
01
521
31
8
71
44
02
5
57
71
31
03
02
24
11
4536
Test for heterogeneity: H = 0.777; Q = 3.620; d.f. = 6; P = 0.728; I2 = 0
(100)
Favours LLRFavours OLR
0.1 1 10
Figure 7 Pooled estimates of overall survival rate after laparoscopic liver resection (LLR) vs. open liver resction (OLR) for hepatocellular
carcinoma (HCC). The solid squares denote individual odds ratios (OR) and the horizontal lines represent 95% confidence intervals (CI). The
diamonds denote overall pooled OR
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Figure 8 Pooled estimates of the disease-free survival rate after laparoscopic liver resection (LLR) vs. open liver resction (OLR) for
hepatocellular carcinoma (HCC). The solid squares denote individual odds ratios (OR) and the horizontal lines represent 95% confidence
intervals (CI). The diamonds denote overall pooled OR
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with open surgical incisions, and potentially limit post-operative
rises in portal pressure. In support of this, some studies noted a
significant increase in post-operative cirrhotic decompensa-
tion with OLR compared with LLR (26.1% vs. 7.1%, respectively;
P = 0.03).23,28,41 Similarly, in the present study, we found the rate of
overall and liver specific complications to be lower with LLR.
Further studies are necessary to evaluate this finding inmore detail.
LLR may also be advantageous in cases of HCC complicating
established chronic liver disease. Liver transplantation remains the
main strategy in these cases; however, this is frequently preceded
by liver resection or radiofrequency ablation for disease control,
given the shortage of donor livers. Recent reports have suggested
that liver transplantation after a previous laparotomy is techni-
cally more difficult and associated with significant blood loss.53
Recently, Laurent and colleagues evaluated procedure duration
and blood loss with liver transplantation after a previous LLR or
OLR.54 Patients who underwent a LLR as the first procedure had
shorter operating times and reduced blood loss, suggesting that
LLR may facilitate the transplant procedure.
The present study is subject to a number of limitations. The
studies evaluated in this meta-analysis are non-randomized com-
parative studies and not the highest-quality evidence. Neverthe-
less, it remains unclear if meta-analyses of non-randomized
studies systematically over-estimate effect sizes compared with
meta-analyses of randomized trials,55 and in light of the scarcity of
high-quality evidence in this field, data from the meta-analysis of
non-randomized studies can be informative. A further criticism is
that most studies included in the present analysis were conducted
at large tertiary centres with potentially significant differences in
case mix, protocol and surgical expertise. The low rate of conver-
sion to open surgery, and low peri-operative mortality rates in the
laparoscopic group also suggest that these cases were performed
by experienced surgeons with advanced laparoscopic skills, who
have already ascended their learning curves, thereby limiting gen-
eralizability. Additionally, the degree of statistical heterogeneity
between the meta-analysed publications cautions against over-
interpretation of our results. While the a priori decision to utilize
a random effects model, combined with the use of sensitivity
analyses, helped to diminish the effect of the observed heteroge-
neity, it is unlikely to have abolished it entirely. The authors
acknowledge that this meta-analysis includes a highly diverse col-
lection of procedures, ranging from non-anatomical resection to
right hepatectomy, performed for equally varied indications
including benign disease, CRCM and HCC. Although this is
undoubtedly a limitation, independent data comparing LLR and
OLR for specific pathologies or procedures are scarce at present.
In the future, it will be possible to eliminate this weakness as more
focused studies are conducted. A meta-analysis comparing left
lateral sectionectomy (LLS) by laparoscopic and open means
would be particularly useful as laparoscopic LLS is increasingly
considered the approach of choice by experienced liver surgeons.
In conclusion, the present study indicates that in appropriately
selected cases, LLR results in largely superior peri-operative out-
comes. Analysis of cancer-related outcomes for HCC also suggests
seemingly equivalent oncological results. These findings are in
keeping with evidence that has accumulated over the past decade
from large-scale multi-centre randomized studies on the use of
laparoscopic colorectal surgery for benign and malignant pathol-
ogy.5,56,57 While the challenge of designing and conducting appro-
priate clinical trials for laparoscopic liver resection remains, the
available evidence as summed in the present report suggests that
skilled liver surgeons should not be wary of embracing the lap-
aroscopic approach.
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